Epstein David R

Director at TEM; Officer at Seagen Inc.; Director at Rubius Therapeutics, Inc.

Sold, on record
$4.4M
Dollars the filings state
Form 4 sales
18
Latest Sep 1, 2026
Form 144 notices
2
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

6
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale TEMRoutine
    Sep 2 2025

    Sold 250 shares at $73.64 ($18k)

    Epstein David R, Director

    10b5-1 planSold 0.9% of holdings ($2M position)27,041 shares left0.7x usual sizeFiling

  2. 2 Form 4 sale TEMRoutine
    Nov 3 +62 days

    Sold 370 shares at $90.00 ($33k)

    Epstein David R, Director

    10b5-1 planSold 1.4% of holdings ($2.4M position)26,671 shares left1x usual sizeFiling

  3. 3 Form 4 sale TEMRoutine
    Dec 1 +28 days

    Sold 250 shares at $75.55 ($19k)

    Epstein David R, Director

    10b5-1 planSold 0.9% of holdings ($2M position)26,421 shares left0.7x usual sizeFiling

  4. 4 Form 4 sale TEMRoutine
    Feb 2 +63 days

    Sold 370 shares at $59.41 ($22k)

    Epstein David R, Director

    10b5-1 planSold 1.4% of holdings ($1.6M position)26,051 shares left1x usual sizeFiling

  5. 5 Form 4 sale TEMRoutine
    Mar 2 +28 days

    Sold 250 shares at $50.69 ($13k)

    Epstein David R, Director

    10b5-1 planSold 1% of holdings ($1.3M position)25,801 shares left0.7x usual sizeFiling

  6. 6 Form 4 sale TEMRoutine
    Jun 1 +91 days

    Sold 250 shares at $49.40 ($12k)

    Epstein David R, Director

    10b5-1 planSold 0.8% of holdings ($1.6M position)31,464 shares left0.7x usual sizeFiling

  7. 7 Form 4 sale TEMRoutine
    Aug 3 +63 days

    Sold 370 shares at $43.40 ($16k)

    Epstein David R, Director

    10b5-1 planSold 1.2% of holdings ($1.4M position)31,094 shares left1x usual sizeFiling

  8. 8 Form 4 sale TEMRoutine
    Sep 1 +29 days

    Sold 250 shares at $65.55 ($16k)

    Epstein David R, Director

    10b5-1 planSold 0.8% of holdings ($2M position)30,844 shares left0.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (20)

Form 144 notices and Form 4 sales by Epstein David R
Source
Sep 1, 2026TEMDirectorForm 4 sale250$16k0.8%RoutineSEC
Aug 3, 2026TEMDirectorForm 4 sale370$16k1.2%RoutineSEC
Jun 1, 2026TEMDirectorForm 4 sale250$12k0.8%RoutineSEC
Mar 2, 2026TEMDirectorForm 4 sale250$13k1.0%RoutineSEC
Feb 2, 2026TEMDirectorForm 4 sale370$22k1.4%RoutineSEC
Dec 1, 2025TEMDirectorForm 4 sale250$19k0.9%RoutineSEC
Nov 3, 2025TEMDirectorForm 4 sale370$33k1.4%RoutineSEC
Sep 2, 2025TEMDirectorForm 4 sale250$18k0.9%RoutineSEC
Aug 1, 2025TEMDirectorForm 4 sale370$20k1.3%RoutineSEC
Jun 2, 2025TEMDirectorForm 4 sale250$14k0.9%RoutineSEC
May 1, 2025TEMDirectorForm 4 sale370$20k1.4%RoutineSEC
Mar 17, 2025TEMDirectorForm 4 sale990$46k3.6%RoutineSEC
Mar 3, 2025TEMDirectorForm 4 sale250$14k0.9%RoutineSEC
Feb 3, 2025TEMDirectorForm 4 sale370$20k1.3%RoutineSEC
Dec 11, 2024TEMDirectorForm 4 sale620$26k2.2%RoutineSEC
Dec 11, 2024TEMDirectorForm 144 notice1,240$56kNoticeSEC
Nov 13, 2023Seagen Inc.OfficerForm 144 notice10,620$2.3MNoticeSEC
Nov 10, 2023Seagen Inc.CEOForm 4 sale10,620$2.3M7.2%No planSEC
Feb 11, 2021Rubius Therapeutics, Inc.DirectorForm 4 sale26,704$399k0.6%Plan not statedSEC
Feb 10, 2021Rubius Therapeutics, Inc.DirectorForm 4 sale98,737$1.5M2.1%Plan not statedSEC